Pathology and Lab Medicine
Episodes 1-16 of 23
Nadia Harbeck, MD, PhD
- MinuteCE®
Endpoints in Adjuvant Breast Cancer Trials: Implications for Clinical Practice
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Hope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Nadia Harbeck, MD, PhD
- MinuteCE®
Differentiating Safety Profiles of CDK4/6 Inhibitor Combination Regimens
1.25 program creditsHope S. Rugo, MD, FASCO
Nadia Harbeck, MD, PhD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Alexander Drilon, MD
Charu Aggarwal, MD, MPH
Charu Aggarwal, MD, MPH
- Prev
- Next